Cargando…
Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden
BACKGROUND: Little comparative evidence is available on utilisation of cancer medicines in different countries and its determinants. The aim of this study was to develop a statistical model to test the correlation between utilisation and possible determinants in selected European countries. METHODS:...
Autor principal: | Ferrario, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641289/ https://www.ncbi.nlm.nih.gov/pubmed/27942986 http://dx.doi.org/10.1007/s10198-016-0855-5 |
Ejemplares similares
-
Cancer Organizations in France, Belgium, England, Germany and Sweden
por: Spies, John W.
Publicado: (1931) -
Medicine in Scotland in the Early Part of the Eighteenth Century
por: Allan, Geo. A.
Publicado: (1920) -
Determinants of emergency physician wellness in Belgium
por: Somville, Francis, et al.
Publicado: (2020) -
Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study
por: Vandenplas, Yannick, et al.
Publicado: (2022) -
Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies
por: Mueller, Tanja, et al.
Publicado: (2017)